Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older of any gender
- People who have a new suspected diagnosis of a blood cancer called acute myeloid leukemia (AML), identified using a standard set of medical guidelines called ELN2022 criteria
- People who are able to understand what the study involves and what they are agreeing to
- People who are willing to sign a consent form agreeing to take part in the study
Note: The trial also includes a separate group using stored biological samples (such as bone marrow and blood samples) already collected from AML patients between June 2006 and June 2024, where consent for research use was already given at the time of collection.
Who may not be able to join:
- People under the age of 18
- People who are unable or unwilling to sign the consent form agreeing to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0226433917
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Inflammasome Activity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.